French cancer charity charged with misuse of funds
This article was originally published in Clinica
Executive Summary
Time may be running out for France's largest medical charity, the Association pour la Recherche sur le Cancer, after a leaked report suggested funds had been misused. The agency's president, Jacques Crozemarie, has threatened to shut the charity down after public auditors showed that only 27% of the charity's 1993 income of Fr 581 million ($119 million) was spent on cancer research. The report also questioned the real cost of the charity's fund-raising campaigns, overcharging by printers and unjustified payments.
You may also be interested in...
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.